Status:
COMPLETED
Current Pharmacological Practices in Severe COVID-19
Lead Sponsor:
NMC Specialty Hospital
Conditions:
COVID-19
Eligibility:
All Genders
20-70 years
Brief Summary
The investigators aim to understand the variation in pharmacological therapies for the management of severe coronavirus disease 2019 (COVID-19) in India and compare it to the recent available evidence...
Detailed Description
The ongoing pandemic of COVID-19 has proven to be the greatest medical emergency of recent times. The response of the medical world to this crisis has been unprecedented. The healthcare workers are ca...
Eligibility Criteria
Inclusion
- Physicians who are involved in management of adult patients with severe COVID-19 in India
Exclusion
- Pediatrician Physicians who are not managing severe COVID-19 patients or refused to participate.
Key Trial Info
Start Date :
January 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
1055 Patients enrolled
Trial Details
Trial ID
NCT04691921
Start Date
January 4 2021
End Date
January 31 2021
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reliance Hospital
Mumbai, Mumbai, Mahrastra, India